echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Heavy: Stroke survivors, exercise more, can greatly reduce all-cause mortality

    Heavy: Stroke survivors, exercise more, can greatly reduce all-cause mortality

    • Last Update: 2021-08-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In a study of the general population, the physical activity (PA) and heart blood vessels are closely related disease, stroke and reduce the risk of death, and in a dose-dependent manner
    .


    The graded effects of physical activity have also been confirmed in patients with coronary artery disease, but the beneficial effects on stroke survivors have not been well studied


    Heart blood vessels

    Stroke patients have excessive risk of vascular disease and death in the subacute and chronic stages, so they are suitable candidates for PA-related interventions to reduce this risk
    .


    In addition, there is a high degree of inactivity among stroke survivors living in the community, who have more sitting time and less PA than their age-matched peers


    Stroke

    Current guidelines recommend PA for stroke survivors, but it is mainly based on studies of the general population
    .


    A better understanding of the role of PA in the health of stroke survivors in the community is needed to design better public health campaigns and PA interventions.


    Emphasizes the need for research on all-cause mortality in this group


    Specifically, the Canadian Community Health Survey is used to obtain self-reported physical activity (PA) during the four survey cycles, and is linked with the administrative database to obtain the previous diagnosis of stroke and subsequent all-cause mortality
    .


    Physical activity is measured in metabolic equivalents (METs) per week, and meeting the minimum physical activity criteria is defined as 10 MET-hours/week


    diagnosis

    They found that the cohort included 895 respondents with previous strokes and 97805 controls
    .


    Following the PA guidelines was associated with a lower risk of death in previous stroke patients (adjusted hazard ratio [aHR] 0.
    46, 95% CI 0.
    29-0.
    73) and control groups (aHR 0.
    69, 95% CI 0.


    Both groups have a strong dose-response relationship, with a high early slope, and most of the associated risk reduction occurs between 0-20 MET-hours/week
    .


    In the stroke patient population, PA was associated with a greater risk reduction (aHR 0.


    The important significance of this study lies in the fact that in past stroke patients, especially young stroke survivors, PA has a significant dose-dependent relationship with lower all-cause mortality
    .


    The research results support efforts to reduce barriers to PA and implement PA programs for stroke survivors in the community


    PA has a significant dose-dependent relationship with lower all-cause mortality.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.